Cundy Kenneth C 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
Cundy Kenneth C
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2022-12-09+35,017→ 35,017 totalExercise: $3.37Exp: 2032-12-08→ Common Stock (35,017 underlying)
Footnotes (1)
- [F1]The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022.